|
1
|
Shah H: Perthes disease: Evaluation and
management. Orthop Clin North Am. 45:87–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim HK: Pathophysiology and new strategies
for the treatment of Legg-Calvé-Perthes disease. J Bone Joint Surg
Am. 94:659–669. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheng TL, Murphy CM, Cantrill LC, Mikulec
K, Carpenter C, Schindeler A and Little DG: Local delivery of
recombinant human bone morphogenetic proteins and bisphosphonate
via sucrose acetate isobutyrate can prevent femoral head collapse
in Legg-Calve-Perthes disease: A pilot study in pigs. Int Orthop.
38:1527–1533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perthes G: Concerning arthritis deformans
juvenilis. 1910. Clin Orthop Relat Res. 451:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Legg AT: An obscure affection of the hip
joint. 1910. Clin Orthop Relat Res. 451:11–13. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calvé J: On a particular form of
pseudo-coxalgia associated with a characteristic deformity of the
upper end of the femur. Clin Orthop Relat Res. 451:14–16. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wiig O, Terjesen T, Svenningsen S and Lie
SA: The epidemiology and aetiology of Perthes' disease in Norway. A
nationwide study of 425 patients. J Bone Joint Surg Br.
88:1217–1223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Alpaslan AM, Aksoy MC and Yazici M:
Interruption of the blood supply of femoral head: An experimental
study on the pathogenesis of Legg-Calve-Perthes disease. Arch
Orthop Trauma Surg. 127:485–491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Glueck CJ, Freiberg RA and Wang P: Role of
thrombosis in osteonecrosis. Curr Hematol Rep. 2:417–422.
2003.PubMed/NCBI
|
|
10
|
Marsden PA, Schappert KT, Chen HS, Flowers
M, Sundell CL, Wilcox JN, Lamas S and Michel T: Molecular cloning
and characterization of human endothelial nitric oxide synthase.
FEBS Lett. 307:287–293. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marsden PA, Heng HH, Scherer SW, Stewart
RJ, Hall AV, Shi XM, Tsui LC and Schappert KT: Structure and
chromosomal localization of the human constitutive endothelial
nitric oxide synthase gene. J Biol Chem. 268:17478–17488.
1993.PubMed/NCBI
|
|
12
|
Fairchild TA, Fulton D, Fontana JT,
Gratton JP, McCabe TJ and Sessa WC: Acidic hydrolysis as a
mechanism for the cleavage of the Glu (298)->Asp variant of
human endothelial nitric-oxide synthase. J Biol Chem.
276:26674–26679. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lembo G, De Luca N, Battagli C, Iovino G,
Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C and Trimarco
B: A common variant of endothelial nitric oxide synthase
(Glu298Asp) is an independent risk factor for carotid
atherosclerosis. Stroke. 32:735–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abdel-Aziz TA and Mohamed RH: Association
of endothelial nitric oxide synthase gene polymorphisms with
classical risk factors in development of premature coronary artery
disease. Mol Biol Rep. 40:3065–3071. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Balligand JL, Feron O and Dessy C: eNOS
activation by physical forces: From short-term regulation of
contraction to chronic remodeling of cardiovascular tissues.
Physiol Rev. 89:481–534. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Doshi AA, Ziolo MT, Wang H, Burke E,
Lesinski A and Binkley P: A promoter polymorphism of the
endothelial nitric oxide synthase gene is associated with reduced
mRNA and protein expression in failing human myocardium. J Card
Fail. 16:314–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Levinsson A, Olin AC, Björck L, Rosengren
A and Nyberg F: Nitric oxide synthase (NOS) single nucleotide
polymorphisms are associated with coronary heart disease and
hypertension in the INTERGENE study. Nitric Oxide. 39:1–7. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bellini MH, Figueira MN, Piccoli MF,
Marumo JT, Cendoroglo MS, Neto MC, Dalboni MA, Batista MC, Goes MA
and Schor N: Association of endothelial nitric oxide synthase gene
intron 4 polymorphism with end-stage renal disease. Nephrology
(Carlton). 12:289–293. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spoto B, Benedetto FA, Testa A, Tripepi G,
Mallamaci F, Maas R, Boeger RH and Zoccali C: An additive effect of
endothelial nitric oxide synthase gene polymorphisms contributes to
the severity of atherosclerosis in patients on dialysis. Am J
Hypertens. 20:758–763. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng L, Wang W, Ni J, Li Z and Xiao T:
The association of eNOS gene polymorphism with avascular necrosis
of femoral head. PloS One. 9:e875832014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ferguson AB Jr: Segmental vascular changes
in the femoral head in children and adults. Clin Orthop Relat Res.
291–298. 1985.PubMed/NCBI
|
|
22
|
Launder WJ, Hungerford DS and Jones LH:
Hemodynamics of the femoral head. J Bone Joint Surg Am. 63:442–448.
1981.PubMed/NCBI
|
|
23
|
Woratanarat P, Thaveeratitharm C,
Woratanarat T, Angsanuntsukh C, Attia J and Thakkinstian A:
Meta-analysis of hypercoagulability genetic polymorphisms in
Perthes disease. J Orthop Res. 32:1–7. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Aksoy MC, Aksoy DY, Haznedaroglu IC,
Sayinalp N, Kirazli S and Alpaslan M: Enhanced tissue factor
pathway inhibitor response as a defense mechanism against ongoing
local microvascular events of Legg-Calve-Perthes disease. Pediatr
Hematol Oncol. 22:391–399. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aksoy MC, Aksoy DY, Haznedaroglu IC,
Sayinalp N, Kirazli S and Alpaslan M: Thrombomodulin and GFC levels
in Legg-Calve-Perthes disease. Hematology. 13:324–328. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gamboa A, Okamoto LE, Diedrich A, Choi L,
Robertson D, Farley G, Paranjape S and Biaggioni I: Sympathetic
activation and nitric oxide function in early hypertension. Am J
Physiol Heart Circ Physiol. 302:H1438–H1443. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cooke JP: NO and angiogenesis. Atheroscler
Suppl. 4:53–60. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Murohara T, Asahara T, Silver M, Bauters
C, Masuda H, Kalka C, Kearney M, Chen D, Symes JF, Fishman MC, et
al: Nitric oxide synthase modulates angiogenesis in response to
tissue ischemia. J Clin Invest. 101:2567–2578. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsukada T, Yokoyama K, Arai T, Takemoto F,
Hara S, Yamada A, Kawaguchi Y, Hosoya T and Igari J: Evidence of
association of the ecNOS gene polymorphism with plasma NO
metabolite levels in humans. Biochem Biophys Res Commun.
245:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshimura M, Yasue H, Nakayama M,
Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, Ogawa H, Ogawa Y,
Saito Y, et al: A missense Glu298Asp variant in the endothelial
nitric oxide synthase gene is associated with coronary spasm in the
Japanese. Hum Genet. 103:65–69. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horstman LL, Jy W, Jimenez JJ and Ahn YS:
Endothelial microparticles as markers of endothelial dysfunction.
Front Biosci. 9:1118–1135. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eldridge J, Dilley A, Austin H, EL-Jamil
M, Wolstein L, Doris J, Hooper WC, Meehan PL and Evatt B: The role
of protein C, protein S and resistance to activated protein C in
Legg-Perthes disease. Pediatrics. 107:1329–1334. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hunt DM, Holmes Z, Pickering W and Cohen
H: Correspondence. J Bone Joint Surg Am. 80:604–606.
1998.PubMed/NCBI
|
|
34
|
Van Veldhuizen PJ, Neff J, Murphey MD,
Bodensteiner D and Skikne BS: Decreased fibrinolytic potential in
patients with idiopathic avascular necrosis and transient
osteoporosis of the hip. Am J Hematol. 44:243–248. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
de Marco KC, Antunes LM, Tanus-Santos JE
and Barbosa F Jr: Intron 4 polymorphism of the endothelial nitric
oxide synthase (eNOS) gene is associated with decreased NO
production in a mercury-exposed population. Sci Total Environ.
414:708–712. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saini V, Bhatnagar MK and Bhattacharjee J:
Endothelial nitric oxide synthase Glu298Asp (G894T) gene
polymorphism in coronary artery disease patients with type 2
diabetes mellitus. Diabetes Metab Syndr. 6:106–109. 2012.
View Article : Google Scholar : PubMed/NCBI
|
